Cancer and Inflammation Program Retreat
April 10-11, 2008

CIP Retreat Posters

Day 1 -- April 10, 2008

Presenter

Number

Title

Oppenheim
Zack Howard 1 Biologically Active Self Assembling Nanoparticle Targeting CXCR4:  Novel Antitumor Modality
Teizo Yoshimura 2 The Role of Leukocyte Chemoattractants and Chemoattractant Receptors in Inflammation and Cancer.
Poonam Tewary 3 Some alarmins activate antigen presenting cells through the Receptor for advanced glycation end products (RAGE)
De Yang 4 Gadolinium-containing fullerenol nanoparticle Gd@C82(OH)22 promotes Th1 immune response and exhibits anti-tumor effect

Wang
Keqiang. Chen 5 An essential role of the G protein-coupled formylpeptide receptor mFPR2 in the development of allergic airway inflammation
Jian Huang 6 The formylpeptide receptor FPR exploits the function of EGFR to  promote the progression of glioblastoma

Ruscetti
Kathryn Jones 7 Molecular minicry of a VEGF domian by HTLV-1 envelope promotes HTLV-1 entry via heparan sulfate proteoglycans and neuropilin-1
Maria Birchenall-Roberts 8 SpA-1, novel class of RapGTPase regulators, associates with transforming growth factor-beta type I/II receptors

Hurwitz
Kim Shafer-Weaver 9 Provision of tumor-specific CD4+ T cells to enhance tumor immunity in a murine model of prostate cancer
Vinod Singh 10 Tumor progression despite the presence of functional tumor-infiltrating CD8+ T cells

Sayers
Alan Brooks 11 Molecular mechanisms underlying sensitization of human renal carcinomas to TRAIL apoptosis following proteasome inhibition by bortezomib
Anil Shanker 12 Effect of bortezomib-induced proteasome inhibition on anti-tumor T cell responses in vivo.

Anderson
Hongchuan Li 13 Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression
Neeraj Sharma 14 Control of KIR expression by endogenous antisense transcripts

McVicar
Selinda Orr 15 Development of a Novel Approach for Genetic Manipulation of Primary Murine NK cells in vivo

Young
Debbie Hodge 16 Phenotypic changes in IFN-gamma 3’UTR ARE knock out mice
Sagie Wagage 17 Interferon-beta expression by Lactobacillus: In Vitro Characterizations

Durum
Wenqing Li 18 Lactococcus lactis delivery of proteins to inhibit inflammatory bowel disease


Day 2 -- April 11, 2008

Dean
Bert Gold 19 Genome wide association study of Ashkenazi Jews provides evidence for an estrogen regulated new breast cancer risk locus
Julie Bergeron 20 Alternative Complement Pathway Genes and Oxidative Stress Loci strongly associate with age related macular degeneration (AMD)
Bert Gold 21 A Tapestry of Human Ancestral Recombination at the Duffy antigen receptor for chemokines (DARC) locus
Zhang-Qun Chen 22 ABC genes expression in Myeloma putative stem cells

Carrington
Smita Kulkarni 23 New Innate correlates of AIDS progression
Pat Martin 23 Diversity of the KIR gene cluster
Xiao Jiang Gao 25 HLA-B polymorphism of HIV carriers but not recipients affects viral transmission between heterosexual couples
Rasmi Thomas 26 Genetic attempts to decrypt the -35 HLA-C Promoter Polymorphism effect on HIV

Klinman
Sven Klaschik 27 Patterned Gene Expression Induced by CpG DNA Mediated TLR9 Activation in vivo

Trinchieri
Lyudmila Lyakh 28 Differential regulation of IL-12 and IL-23 production by human dendritic cells
Zsofia Gyulai 29 Role of TNF in colon carcinogenesis

Wiltrout
Jon Weiss 30 Agonistic antibody to CD40 induces CCL2/CCR2- dependent anti-tumor responses whereas IL-2/anti-CD40 synergy involves multiple chemokines and effector leukocyte mechanisms.
Jeff Subleski 31 Acute inflammation with IL-18/IL-12 or a-GalCer treatment induces liver iNKT cell apoptosis and repopulation from peripheral tissues, whereas chronic inflammation ablates systemic iNKT cells with thymic-dependent repopulation
Veronica Hall 32 RENCA Increases TNFR2 T-reg Population In The Tumor Microenvironment
Tim Chan 33 Differential in vivo modulatory effects of systemic IL-12 therapy on hepatic and splenic dendritic cells

Flow Core
Kathleen Noer 34 Capabilties of the Frederick-CCR Flow Cytometry Core
Contact Information

For Scientific Information:
contact Howard Young
(301-846-5700)

For Registration/Hotel Information:
contact Cheryl Lamb
(301-846-1551)

Location
National Cancer Institute National Institutes of Health Human and Health Services